4D Molecular Therapeutics (FDMT) Shareholder's Equity (2019 - 2026)
4D Molecular Therapeutics (FDMT) Shareholder's Equity (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 7.14 Bn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.79 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 595,226.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.00 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 14.38 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 502.95 Mn |
| 10 | 4D Molecular Therapeutics | 656.48 Mn | 656.48 Mn | - | 451.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 451.84 Mn |
| Dec 31, 2025 | 505.66 Mn |
| Sep 30, 2025 | 368.98 Mn |
| Jun 30, 2025 | 420.89 Mn |
| Mar 31, 2025 | 469.72 Mn |
| Dec 31, 2024 | 510.61 Mn |
| Sep 30, 2024 | 552.95 Mn |
| Jun 30, 2024 | 588.34 Mn |
| Mar 31, 2024 | 600.56 Mn |
| Dec 31, 2023 | 307.83 Mn |
| Sep 30, 2023 | 329.93 Mn |
| Jun 30, 2023 | 325.14 Mn |
| Mar 31, 2023 | 218.61 Mn |
| Dec 31, 2022 | 231.34 Mn |
| Sep 30, 2022 | 251.44 Mn |
| Jun 30, 2022 | 272.52 Mn |
| Mar 31, 2022 | 296.06 Mn |
| Dec 31, 2021 | 319.11 Mn |
| Sep 30, 2021 | 224.13 Mn |
| Jun 30, 2021 | 240.65 Mn |